Live Breaking News & Updates on Central drugs standard control organisations

Stay informed with the latest breaking news from Central drugs standard control organisations on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Central drugs standard control organisations and stay connected to the pulse of your community

Plea in Delhi HC seeking stay on Phase II/III clinical trial of Covaxin in 2 to 18 age group

New Delhi [India], June 3 (ANI): A Fresh application was moved in Delhi High Court on Thursday seeking to stay the operation of the order of Drugs Controller General of India (DCGI) for conducting phase II/III clinical trials of Whole Virion Inactivated Coronavirus Vaccine in the 2 to 18 years age group.

Delhi , India , New-delhi , Bharat , Sanjeev-kumar , Bharat-biotec-ltd , Delhi-high-court , Delhi-high-court-on , Drugs-controller-general , Whole-virion-inactivated-coronavirus-vaccine , Central-drugs-standard-control-organisations , Bharat-biotech

When can I get the COVID-19 vaccine


When can I get the COVID-19 vaccine
On January 16, 2021, India rolled out the world's largest vaccination drive in the fight against COVID-19.
0 claps
Central Drugs Standard Control Organisations (CDSCO), too, has approved two vaccines —
Covishield and Covaxin. 
Both Covishield (AstraZeneca vaccine manufactured by Serum Institute of India) and Covaxin (manufactured by Bharat Biotech Limited) have been approved for emergency restricted use in India. 
When can I get the vaccine? 
Taking the availability of vaccines into consideration, the Indian government has divided the vaccine distribution into various categories, with some of the first doses going to selected priority groups who are at higher risk of contracting the deadly virus. 

India , Bharat , Covishield-astrazeneca , Aarogya-setu , Bharat-biotech , National-expert-group-on-vaccine-administration , Serum-institute-of-india , Central-drugs-standard-control-organisations , Serum-institute , Bharat-biotech-limited , National-expert-group , Vaccine-administration